Altimmune, Inc. - Common Stock (ALT)

CUSIP: 02155H200

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
104,413,190
Total 13F shares
39,903,915
Share change
+6,264,792
Total reported value
$466,872,641
Put/Call ratio
11%
Price per share
$11.70
Number of holders
102
Value change
+$78,793,572
Number of buys
61
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 02155H200?
CUSIP 02155H200 identifies ALT - Altimmune, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ALT - Altimmune, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Nuveen Asset Management, LLC
13F
Company
3.1%
3,245,204
$22,197,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
2.8%
2,936,324
$17,882,000 31 Mar 2022
13F
Avidity Partners Management LP
13F
Company
2.7%
2,865,000
$17,448,000 31 Mar 2022
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2.5%
2,573,744
$15,674,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
1.7%
1,816,915
$11,065,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
1.3%
1,407,866
$8,574,000 31 Mar 2022
13F
ARDSLEY ADVISORY PARTNERS LP
13F
Company
1.3%
1,353,000
$8,240,000 31 Mar 2022
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
1.3%
1,306,953
$7,959,000 31 Mar 2022
13F
BARCLAYS PLC
13F
Company
1.1%
1,155,281
$7,037,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
1.1%
1,124,407
$6,848,000 31 Mar 2022
13F
BAKER BROS. ADVISORS LP
13F
Company
1%
1,072,038
$6,529,000 31 Mar 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.93%
967,736
$5,893,000 31 Mar 2022
13F
Woodline Partners LP
13F
Company
0.81%
846,618
$5,156,000 31 Mar 2022
13F
CITIGROUP INC
13F
Company
0.76%
790,127
$4,812,000 31 Mar 2022
13F
VR Adviser, LLC
13F
Company
0.73%
759,719
$4,627,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.7%
728,869
$4,439,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.67%
697,160
$4,246,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
0.66%
691,141
$4,209,000 31 Mar 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.66%
690,800
$4,207,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.61%
641,821
$3,908,000 31 Mar 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.58%
604,420
$3,681,000 31 Mar 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.47%
495,061
$3,015,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.37%
388,700
$2,367,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
0.34%
360,127
$2,193,000 31 Mar 2022
13F
Altium Capital Management LLC
13F
Company
0.31%
322,000
$1,961,000 31 Mar 2022
13F
DCF Advisers, LLC
13F
Company
0.3%
316,000
$1,924,000 31 Mar 2022
13F
Parkman Healthcare Partners LLC
13F
Company
0.3%
309,586
$1,885,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.29%
307,589
$1,873,000 31 Mar 2022
13F
HRT FINANCIAL LP
13F
Company
0.21%
222,368
$1,354,000 31 Mar 2022
13F
Walleye Capital LLC
13F
Company
0.2%
211,753
$1,290,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.19%
197,247
$1,201,000 31 Mar 2022
13F
NORGES BANK
13F
Company
0.18%
189,600
$1,154,664 31 Mar 2022
13F
Beirne Wealth Consulting Services, LLC
13F
Company
0.18%
183,840
$1,117,000 31 Mar 2022
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
0.17%
182,000
$1,108,000 31 Mar 2022
13F
Knoll Capital Management, LLC
13F
Company
0.13%
132,978
$810,000 31 Mar 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.12%
125,219
$763,000 31 Mar 2022
13F
PDT Partners, LLC
13F
Company
0.12%
124,377
$757,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.1%
104,222
$635,000 31 Mar 2022
13F
Trexquant Investment LP
13F
Company
0.1%
99,269
$605,000 31 Mar 2022
13F
Squarepoint Ops LLC
13F
Company
0.09%
94,627
$576,000 31 Mar 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.09%
89,485
$545,000 31 Mar 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.07%
72,702
$443,000 31 Mar 2022
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.06%
62,500
$381,000 31 Mar 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
50,234
$306,000 31 Mar 2022
13F
GROUP ONE TRADING LLC
13F
Company
0.05%
49,406
$301,000 31 Mar 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.04%
46,734
$285,000 31 Mar 2022
13F
ALPS ADVISORS INC
13F
Company
0.04%
40,836
$249,000 31 Mar 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.04%
39,053
$238,000 31 Mar 2022
13F
William Michael Brown
3/4/5
Chief Financial Officer
class O/S missing
17,721
$199,361 31 Jul 2021
Vahanian & Associates Financial Planning Inc.
13F
Company
0.03%
31,426
$191,000 31 Mar 2022
13F

Institutional Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2022

As of 30 Jun 2022, Altimmune, Inc. - Common Stock (ALT) was held by 102 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,903,915 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, Nuveen Asset Management, LLC, Cormorant Asset Management, LP, Avidity Partners Management LP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., MORGAN STANLEY, ARDSLEY ADVISORY PARTNERS LP, and CITADEL ADVISORS LLC. This page lists 102 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
96
Q2 2022 holders
102
Holder diff
6
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.